Author

Mirzet Delic

University of Zurich

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:spatial transcriptomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Adriano AguzziiD· 2 shared Andra ChincisaniD· 1 shared Anna Maria ReussiD· 1 shared Athena E. EconomidesiD· 1 shared Chiara TrevisaniD· 1 shared Claudia ScheckeliD· 1 shared Daniel HeinzeriD· 1 shared Daniel KirschenbaumiD· 1 shared

Activity by Year

2020-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Adriano AguzziORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Quantitative 3D histochemistry reveals region-specific amyloid-β reduction by the antidiabetic drug netoglitazone

Francesca Catto, Daniel Kirschenbaum, Athena E. Economides, Anna Maria Reuss, Chiara Trevisan, Davide Caredio, Ehsan Dadgar‐Kiani, Mirzet Delic, Lukas D. Frick, Ulrike Weber‐Stadlbauer, Sergey Litvinov, Petros Koumoutsakos, Jin Hyung Lee, Adriano Aguzzi

This study uses quantitative 3D histochemistry to show that netoglitazone reduces amyloid-beta plaques in specific brain regions of a mouse AD model.

PLOS One · May 6, 2025Peer-reviewedNeuroscience

Genome-wide transcriptomics identifies an early preclinical signature of prion infection

Silvia Sorce, Mario Nuvolone, Giancarlo Russo, Andra Chincisan, Daniel Heinzer, Merve Avar, Manuela Pfammatter, Petra Schwarz, Mirzet Delic, Micha Müller, Simone Hornemann, Despina Sanoudou, Claudia Scheckel, Adriano Aguzzi

The paper identifies early molecular changes in prion-infected mice, suggesting glial pathophysiology as a key driver and potential targets for intervention.

PLoS Pathogens · Jun 29, 2020Peer-reviewedNeuroscience